The present study adopted an observational design including only antihypertensive drug naïve patients newly received an antihypertensive agent without oral hypoglycemic agents or insulin use, concomitant cardiovascular disorders or other medical conditions which could confound choice of prescriptions. The gene discussed is INS; the disease is cardiovascular disorder.